Additionally, EPCs from COPD patients have been shown to be dysfunctional in proliferation and migration assays in response to specific chemotactic factors (i.e. SDF-1α) [58–61], which may be responsible for a change in circulating EPCs. The gene discussed is CXCL12; the disease is chronic obstructive pulmonary disease.